0.9% Sodium Chloride Injection clinical trials
3 indexed studies · 0 currently recruiting
- Ongoing, recruitingPhase I and Phase II (Integrated)- Other
A Phase 1/2, Safety Confirmation, Placebo-controlled, Randomized Study of Nivolumab in Combination with Relatlimab and Bevacizumab in Treatment-naive Advanced/Metastatic Hepatocellular Carcinoma (RELATIVITY-106)
This study is testing new combinations of medicines for advanced liver cancer. We want to see if these treatments are safe and how well they shrink cancer or stop it from growing. It will involve different groups of patients trying different treatment plans.
For: Advanced/metastatic hepatocellular carcinoma (HCC)Germany · Spain · France - Ongoing, recruitingPhase I and Phase II (Integrated)- First administration to humans
A Global, Phase 1/2 Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of mRNA-3705 in Participants with Isolated Methylmalonic Acidemia Due to Methylmalonyl-CoA Mutase Deficiency
This study is testing a new medicine, mRNA-3705, for a rare genetic condition called methylmalonic acidemia (MMA). Doctors want to see if the medicine is safe, how the body handles it, and if it helps reduce harmful acid levels in the blood.
For: Isolated Methylmalonic Acidemia Due to Methylmalonyl-CoA Mutase DeficiencyFrance · Netherlands · Spain - Ongoing, recruitingTherapeutic exploratory (Phase II)
17 β-Hydroxysteroid Dehydrogenase type 13 Minimization for the treatment of NASH (HORIZON): A Double-Blind, Placebo-Controlled Phase 2b Study to Evaluate the Efficacy and Safety of GSK4532990 in Adults with Nonalcoholic Steatohepatitis
This study is looking into a new medication for a liver condition called Non-Alcoholic Steatohepatitis (NASH). It aims to see if the medication can help improve liver scarring and reduce the illness, for people aged 18 and over.
Greece · Italy · Belgium